Sanqi oral solution alleviates podocyte apoptosis in experimental membranous nephropathy by mediating EMT through the ERK/CK2-α/β-catenin pathway

IntroductionSanqi oral solution (SQ) is a Chinese medicine that has been used well to treat idiopathic membranous nephropathy (IMN). It has been demonstrated to mitigate IMN proteinuria by inhibiting podocyte apoptosis. however, the precise mechanism has not been fully elucidated.MethodsA passive He...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xiaowan Wang, Juanjuan Wang, Bidan Zheng, Ruimin Tian, Lihua Huang, Wei Mao, Yi Feng, Bo Liu, Peng Xu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-05-01
coleção:	Frontiers in Pharmacology
Assuntos:	passive heymann nephropathy sanqi oral solution apoptosis epithelialmesenchymal transition the ERK/CK2-α/β-catenin pathway
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1503961/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!